HCV genotype | 12–25 years | 26–35 years | 36–45 years | 46–55 years | 56–65 years | Total ⩽45 years | Total >45 years | Overall |
---|---|---|---|---|---|---|---|---|
Total Dionysos population | 1464 (21.2) | 1347 (19.5) | 1354 (19.6) | 1368 (19.8) | 1384 (20.0) | 4165 (60.2) | 2752 (39.8) | 6917 |
Anti-HCV positive | 9 (4.0) | 20 (8.8) | 26 (11.5) | 56 (24.8) | 115 (50.9) | 55 (24.3) | 171 (75.7)1-150 | 226 (3.2) |
HCV-RNA positive | 5 (3.1) | 14 (8.6) | 12 (7.4) | 43 (26.5) | 88 (54.3) | 31 (19.1) | 131 (80.9)1-150 | 162 (2.3) |
Type 1a | 0 (0.0) | 2 (28.6) | 1 (14.3) | 2 (28.6) | 2 (28.6) | 3 (42.9) | 4 (57.1) | 7 (0.1) |
Type 1b | 1 (1.5) | 5 (7.4) | 5 (7.4) | 23 (33.8) | 34 (50.0) | 11 (16.2) | 57 (83.8)1-150 | 68 (1.0) |
Type 2a | 1 (2.6) | 1 (2.6) | 4 (10.3) | 12 (30.8) | 21 (53.8) | 6 (15.4) | 33 (84.6)1-150 | 39 (0.6) |
Type 2b | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100) | 0 (0.0) | 1 (100) | 1 (0.01) |
Type 2c | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (50.0) | 2 (50.0) | 0 (0.0) | 4 (100) | 4 (0.06) |
Type 3a | 0 (0.0) | 2 (66.7) | 0 (0.0) | 0 (0.0) | 1 (33.3) | 2 (66.7) | 1 (33.3) | 3 (0.04) |
Co2 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (100) | 0 (0.0) | 3 (100) | 3 (0.04) |
Co3 | 0 (0.0) | 3 (27.3) | 1 (9.1) | 1 (9.1) | 6 (54.5) | 4 (36.4) | 7 (63.6) | 11 (0.16) |
UT | 3 (11.5) | 1 (3.8) | 1 (3.8) | 3 (11.5) | 18 (69.2)† | 5 (19.2) | 21 (80.8)1-150 | 26 (0.38) |
Values in parentheses are percentages.
Co2, coinfections by two HCV genotypes (two patients infected by genotypes 1b and 2b and one by genotype 1b and 2 a); Co3, coinfections by three HCV genotypes (five of the 11 patients infected by genotypes 1a, 1 b and 2a and the other six by genotypes 1b, 2a and 2b); UT, untypable genotypes.
↵1-150 p<0.002 v total⩽ 45; †p<0.01v all the other age ranges.